跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ACCORD 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ACCORD 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ACCORD 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 25, 2020
Approval ID
68d7c62501acb985
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
68d7c62501acb985
Drug Cima Aemps Name
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ACCORD 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85165
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2020-06-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg/5 mg/12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
OLMESARTAN MEDOXOMILO
20 mg
AMLODIPINO BESILATO
6,95 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 25, 2020
Approval ID
68d7c62501acb985
Type
Standard
Back to CIMA-AEMPS Approvals